[HTML] springer.comFull View

[HTML][HTML] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, N Rajendra Prasad - Journal of …, 2022 - Springer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
被引用次数：34 相关文章

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.

P Yadav, SV Ambudkar, R Prasad - Journal of Nanobiotechnology, 2022 - europepmc.org
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
[HTML] biomedcentral.com

[HTML][HTML] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar… - Journal of …, 2022 - jnanobiotechnology.biomedcentral …
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
[HTML] nih.gov

[HTML][HTML] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, NR Prasad - Journal of …, 2022 - ncbi.nlm.nih.gov
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar… - Journal of …, 2022 - search.proquest.com
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
[PDF] academia.edu

[PDF][PDF] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, NR Prasad - 2022 - academia.edu
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.

P Yadav, SV Ambudkar… - Journal of …, 2022 - search.ebscohost.com
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.

P Yadav, SV Ambudkar, R Prasad - Journal of Nanobiotechnology, 2022 - europepmc.org
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
[PDF] biomedcentral.com

[PDF][PDF] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, NR Prasad - 2022 - jnanobiotechnology.biomedcentral …
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …